Economic evaluations are essential to quantitatively assess the evidence leading to the most appropriate public health interventions. Performing economic evaluations can increase societal benefits by decreasing costs and improving health outcomes. This Research Topic will focus on the latest developments in health-economic evaluations of diabetes diagnosis, prevention and treatment — highlighting the health and economic benefits of the different available interventions to diagnose, prevent and treat diabetes.
The aim of this Research Topic is to help governments and decision-makers to have open-access information about the four major types of health-economic evaluations — cost-effectiveness analysis, cost-benefit analysis and cost-minimization analysiss — of interventions on diabetes to enable them to make informed decisions and maximize health and economic benefits.
In this Research Topic, we will consider original research and review articles exploring Health economic Evaluations of diabetes prevention, diagnosis and treatment. Topics include, but are not limited to:
- Cost-effectiveness, cost-benefit, and cost-minimization studies of different diabetes treatments
- Cost-effectiveness, cost-benefit and cost-minimization studies of diabetes prevention strategies
- Cost-effectiveness, cost-benefit and cost-minimization studies of diabetes diagnosis
- Public health policies on diabetes treatment and prevention at the national and international level
- Economic impact of diabetes, economic impact analysis
- Trial-Based Economic Evaluation and Economic Model or Factor Analysis.
Keywords:
health economics, diabetes mellitus, diabetes type 1, diabetes type 2, pharmacoeconomics, cost-benefit analysis, cost-effectiveness analysis, cost-utility analysis, cost-minimization analysis
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Economic evaluations are essential to quantitatively assess the evidence leading to the most appropriate public health interventions. Performing economic evaluations can increase societal benefits by decreasing costs and improving health outcomes. This Research Topic will focus on the latest developments in health-economic evaluations of diabetes diagnosis, prevention and treatment — highlighting the health and economic benefits of the different available interventions to diagnose, prevent and treat diabetes.
The aim of this Research Topic is to help governments and decision-makers to have open-access information about the four major types of health-economic evaluations — cost-effectiveness analysis, cost-benefit analysis and cost-minimization analysiss — of interventions on diabetes to enable them to make informed decisions and maximize health and economic benefits.
In this Research Topic, we will consider original research and review articles exploring Health economic Evaluations of diabetes prevention, diagnosis and treatment. Topics include, but are not limited to:
- Cost-effectiveness, cost-benefit, and cost-minimization studies of different diabetes treatments
- Cost-effectiveness, cost-benefit and cost-minimization studies of diabetes prevention strategies
- Cost-effectiveness, cost-benefit and cost-minimization studies of diabetes diagnosis
- Public health policies on diabetes treatment and prevention at the national and international level
- Economic impact of diabetes, economic impact analysis
- Trial-Based Economic Evaluation and Economic Model or Factor Analysis.
Keywords:
health economics, diabetes mellitus, diabetes type 1, diabetes type 2, pharmacoeconomics, cost-benefit analysis, cost-effectiveness analysis, cost-utility analysis, cost-minimization analysis
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.